The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.

Mukherjee A, Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. · 2011

Read The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. by Mukherjee A, Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3059221.txt.

Introduction

Mukherjee and colleagues showed in 2011 how a common childhood virus disarms the cell's antiviral alarm by cutting two key adaptor proteins. Coxsackievirus B3 carries a scissor enzyme that the team found snipping both adaptors in infected cells. Those adaptors normally pass danger signals onward to trigger interferon, the cell's main antiviral messenger, and to order infected cells to self destruct.

Cutting one adaptor tore it away from the cell power stations where it must sit to work, silencing its signal. Cutting the second adaptor at both ends scrambled the signaling hub it assembles. Both cuts depended on the enzyme's scissor activity and hit precise sites. The result is a virus that muffles two alarm routes with one tool. Such tricks help explain how this virus establishes infection, and they name targets for future antiviral design.

Catalog record

CREATORMukherjee A, Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC0 1.0 Universal
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3059221

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Coxsackievirus B 3Cpro Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling By Amitava Mukherjee, Stefanie A. Morosky, Elizabeth Delorme-Axford, Naomi Dybdahl-Sissoko, M. Steven Oberste, Tianyi Wang, Carolyn B. Coyne, Mark Heise Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.1001311 ABSTRACT The host innate immune response to viral infections often involves the activation of parallel pattern recognition receptor (PRR) pathways that converge on the induction of type I interferons (IFNs). Several viruses have evolved sophisticated mechanisms to attenuate antiviral host signaling by directly interfering with the activation and/or downstream signaling events associated with PRR signal propagation. Here we show that the 3Cpro cysteine protease of coxsackievirus B3 (CVB3) cleaves the innate immune adaptor molecules mitochondrial antiviral signaling protein (MAVS) and Toll/IL-1 receptor domain-containing adaptor inducing interferon-beta (TRIF) as a mechanism to escape host immunity. We found that MAVS and TRIF were cleaved in CVB3-infected cells in culture. CVB3-induced cleavage of MAVS and TRIF required the cysteine protease activity of 3Cpro, occurred at specific sites and within specialized domains of each molecule, and inhibited both the type I IFN and apoptotic signaling downstream of these adaptors. 3Cpro-mediated MAVS cleavage occurred within its proline-rich region, led to its relocalization from the mitochondrial membrane, and ablated its downstream signaling. We further show that 3Cpro cleaves both the N- and C-terminal domains of TRIF and localizes with TRIF to signalosome complexes within the cytoplasm. Taken together, these data show that CVB3 has evolved a mechanism to suppress host antiviral signal propagation by directly cleaving two key adaptor molecules associated with innate immune recognition. INTRODUCTION The innate immune system is the first line of defense against pathogen infiltration and is activated by the binding of conserved microbial ligands to pattern recognition receptors (PRRs). Activation of these receptors culminates in nuclear factor (NF)-κB and/or IFN regulatory factor (IRF)-mediated induction of type 1 interferons (IFN-α and -β), key components of antimicrobial host defenses. PRRs, including Toll-like receptors (TLRs) and DExD/H box RNA helicases, signal through an assortment of downstream adaptor molecules to propagate innate immune signaling. TLRs signal through adaptor molecules such as myeloid differentiation factor 88 (MyD88), Toll/IL-1 receptor domain containing adaptor protein (TIRAP), Toll/IL-1 receptor domain containing adaptor inducing interferon-beta (TRIF), and TRIF-related adaptor molecule (TRAM) to activate cellular defenses [1]. These adaptors often display specificity with regard to the TLR family members with whom they interact with and from which they are activated. The specificity of TLR ectodomain-ligand recognition and concomitant specificity in the signaling networks that are engaged by this interaction provides an efficient strategy for microbial recognition. In contrast, activated DExD/H box RNA helicases, which include melanoma differentiation associated gene (MDA5) and retinoic acid induced gene-I (RIG-I), signal to a common downstream adaptor molecule, mitochondrial antiviral signaling [(MAVS), also known as VISA/IPS-1/Cardif] to activate NFκB and IRF3 [2], [3], [4]. MAVS is localized to the mitochondrial membrane and to peroxisomes via a C-terminal transmembrane domain, which is essential for innate immune signaling [5], [6]. PRR-associated adaptor molecules thus serve critical roles in the activation of cellular defenses associated with microbial recognition. As host cells have developed highly specialized strategies for microbial detection and clearance, it is not surprising that many viruses have evolved strategies to counter these defenses in order to promote their replication and spread. In some cases, virally-encoded proteases directly target components of the innate immune system to abolish antiviral signaling via TLRs and/or DExD/H box helicases. Targeted proteolysis of adaptor molecules serves as a powerful means to eliminate antiviral signaling by suppressing common downstream targets of key innate immune signaling pathways. For example, MAVS is cleaved by the NS3/4A serine protease of hepatitis C virus (HCV) [7], the 3Cpro cysteine protease of hepatitis A virus (HAV) [8], the HCV-related GB virus B NS3/4A protease [9], and the 2Apro and 3Cpro proteases of rhinovirus [10]. HCV also utilizes the same NS3/4A serine protease to cleave TRIF in order to silence TLR3-mediated signaling [11]. Thus, the targeting of MAVS and/or TRIF by virally-encoded proteases in order to suppress antiviral signaling is emerging as a common theme in the evasion of host defenses. Enteroviruses, which belong to the Picornaviridae family, are small single-stranded RNA viruses that account for several million symptomatic infections in the United States each year. Coxsackievirus B3 (CVB3), a member of the Enterovirus genus, is associated with a number of diverse syndromes, including meningitis, febrile illness, and diabetes [12] and is an important causative agent of virus-induced heart disease in adults and children [13], [14], [15], [16]. The induction of type I IFN signaling is essential for the control of CVB3 infection, as evidenced by enhanced virus-induced lethality in type I IFN receptor (IFN-α∼β R) null mice [17] and increased susceptibility to CVB3 infection in IFNβ-deficient mice [18]. Both TLR3- and MDA5-mediated type I IFN signaling have been implicated in the response to CVB3 infections and mice deficient in either TRIF or MAVS show an enhanced susceptibility to viral infection [19], [20], [21]. In this study, we determined the potential mechanisms employed by CVB3 to antagonize type I IFN signaling. We found that infection of cells with CVB3 led to the cleavage of the adaptor molecules MAVS and TRIF. Both MAVS and TRIF were cleaved by the CVB3-encoded cysteine protease 3Cpro, indicating that a single protease suppresses innate immune signaling through two powerful pathways. We found that 3Cpro cleaves specific residues within MAVS and TRIF that render these molecules deficient in type I IFN signaling and apoptotic signaling. Taken together, these data suggest that CVB3 has evolved a mechanism to cleave adaptor components of the innate immune system to escape host immunity. RESULTS CVB3 infection does not induce IRF3 nuclear localization or significant type I IFN responses The induction of type I IFNs is the earliest cellular immune response initiated to combat viral infections and is coordinated by the activation of transcription factors such as interferon regulatory factor (IRF)-3, IRF7, and NFκB downstream of PRR activation. We found that CVB3 infection of HEK293 cells led to only a modest induction of IRF3 activation as assessed by immunofluorescence microscopy for nuclear translocation (Figure 1A), western blot analysis of nuclear extracts (Figure 1B), and luciferase activity assays for IFNβ (Figure 1C). In contrast, transfection of cells with poly I:C induced pronounced IRF3 activation (Figure 1A–C). We also observed little activation of NFκB signaling in response to CVB3 infection as determined by luciferase activation assay (Figure 1C). [Figure: CVB3 infection does not induce significant type I IFN responses.HEK293 cells were infected with CVB3 (1 PFU/cell) for 8 hrs or treated with poly I:C conjugated to transfection reagent [poly I:C/LyoVec (100 ng/mL)] for 12 hrs and (A) fixed and stained for virus (VP1, red) and IRF3 (green) or (B) western blot analysis for IRF3 performed on nuclear and cytoplasmic fractions. (C) Luciferase assays (expressed in relative luciferase activity) from HEK293 cells transfected with NFκB and IFNβ promoted luciferase constructs and infected with CVB3 (8 hrs) or treated with 100 ng/mL poly I:C/LyoVec for 12 hrs. Data are shown as mean ± standard deviation. Asterisks indicate p-values of ≤0.05. (D) Luciferase assay (expressed in relative luciferase activity) from HEK293 cells transfected with the indicated constructs and IFNβ promoted luciferase constructs

Read the complete text